Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)

99 filings reported holding PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share as of Q2 2024.
Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 28,117,599 shares of 62,933,385 outstanding shares and own 45% of the company stock.
Largest 10 shareholders include Deep Track Capital, LP (4,184,100 shares), Laurion Capital Management LP (3,861,179 shares), BlackRock Inc. (2,785,895 shares), Balyasny Asset Management L.P. (2,562,942 shares), VANGUARD GROUP INC (2,060,444 shares), Ikarian Capital, LLC (1,662,408 shares), MILLENNIUM MANAGEMENT LLC (1,336,908 shares), STEMPOINT CAPITAL LP (1,202,675 shares), Blue Owl Capital Holdings LP (1,046,025 shares), and GEODE CAPITAL MANAGEMENT, LLC (1,027,711 shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.